Paid Clinical Trials in Rhode Island

Rhode Island has 486 paid clinical trials enrolling now across cities including Providence, Westerly and East Providence. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 31, 2026.

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

444 clinical trials

Applying Directly Observed Therapy to Hydroxyurea to Realize Effectiveness

for Sickle Cell Disease

Sites in Providence +2 more locations

Sponsor: Nationwide Children's Hospital

Sex: All·Age: 11+

Code: NCT06264700·Recruiting·Listed Feb 2024

Apply to this trial

Health Effects of the Standardized Research E-Cigarette in Smokers With HIV Smokers With HIV

for HIV

1 location in Providence

Sponsor: Brown University

Sex: All·Age: 18+

Code: NCT03862924·Recruiting·Listed Mar 2019

Apply to this trial

Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients

for NSCLC, Stage III

Drug: Durvalumab

Sites in Providence +1 more location

Sponsor: Jun Zhang, MD, PhD

Sex: All·Age: 18+

Code: NCT04680377·Recruiting·Listed Dec 2020

Apply to this trial

The Effect of Intrawound Vancomycin Powder on Surgical Site Infection in Inguinal Lymph Node Dissection

for Postoperative Complications

1 location in Providence

Sponsor: Women and Infants Hospital of Rhode Island

Sex: Female·Age: 18+·Accepts healthy volunteers

Code: NCT05625373·Phase 2, Phase 3·Recruiting·Listed Nov 2022

Apply to this trial

TEAPOT Study Multisite

for Hemorrhage, Surgical

Sites in Providence +2 more locations

Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All·Age: 2 - 17

Code: NCT07565753·EARLY_Phase 1·Recruiting·Listed May 2026

Apply to this trial

First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer

for Metastatic Prostate Cancer

Drug: AZD8359

Sites in Providence +3 more locations

Sponsor: AstraZeneca

Sex: Male·Age: 18 - 100

Code: NCT07529717·Phase 1, Phase 2·Recruiting·Listed Apr 2026

Apply to this trial

ALTO-207 in Adults With Treatment-resistant Depression (TRD)

for Treatment-resistant Depression (TRD)

Sites in East Providence +37 more locations

Sponsor: Alto Neuroscience

Sex: All·Age: 18 - 75

Code: NCT07553637·Phase 2·Recruiting·Listed Apr 2026

Apply to this trial

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for Rhabdomyosarcoma

Sites in Providence +61 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 50

Code: NCT07466316·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid Tumours

for Solid Tumours

Sites in Providence +3 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT07446855·Phase 1, Phase 2·Recruiting·Listed Mar 2026

Apply to this trial

Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer

for Advanced Breast Cancer

Drug: Camizestrant

Sites in East Providence +2 more locations

Sponsor: AstraZeneca

Sex: Female·Age: 18+

Code: NCT07427394·Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

for Fibromyalgia

Sites in Cranston +50 more locations

Sponsor: Axsome Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07398417·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

for Biliary Tract Cancer

Drug: Rilvegostomig

Sites in Providence +34 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07221253·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy

for Preeclampsia

Sites in Providence +1 more location

Sponsor: Medical College of Wisconsin

Sex: Female·Age: 18+

Code: NCT07218237·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer

for Prostate Cancer

Sites in Providence +4 more locations

Sponsor: AstraZeneca

Sex: Male·Age: 18+

Code: NCT07192614·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.

for Chronic Kidney Disease and Hypertension

Drug: Dapagliflozin

Sites in East Providence +17 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07222917·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

for Metastatic Prostate Cancer

Sites in Providence +8 more locations

Sponsor: AstraZeneca

Sex: Male·Age: 18 - 130

Code: NCT07181161·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

A Study of DS5361b in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Drug: DS5361b

Sites in Providence +4 more locations

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT07182591·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

for Advanced or Metastatic Non-small Cell Lung Cancer

Sites in Providence +8 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06996782·Phase 1, Phase 2·Recruiting·Listed May 2025

Apply to this trial

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

for Prostate Cancer

Drug: Saruparib

Sites in Providence +37 more locations

Sponsor: AstraZeneca

Sex: Male·Age: 18+

Code: NCT06952803·Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for Cardiovascular Disease

Drug: AZD0780

Sites in Providence +295 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07000357·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

for Chronic Kidney Disease and Hypertension

Drug: Dapagliflozin

Sites in East Providence +116 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06742723·Phase 3·Recruiting·Listed Dec 2024

Apply to this trial

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

for Acute Myeloid Leukemia, Adult

Drug: Venetoclax

Sites in Providence +15 more locations

Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland

Sex: All·Age: 18+

Code: NCT06652438·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

for Endometrial Carcinoma

Sites in Providence, Westerly +325 more locations

Sponsor: National Cancer Institute (NCI)

Sex: Female·Age: 18+

Code: NCT05256225·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

for Gastric Cancer

Sites in Providence +6 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06219941·Phase 2·Recruiting·Listed Jan 2024

Apply to this trial

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

for Ovarian Cancer

Sites in Providence +9 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT05797168·Phase 1, Phase 2·Recruiting·Listed Apr 2023

Apply to this trial

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

for Metastatic Head and Neck Squamous Cell Carcinoma

Sites in Providence +49 more locations

Sponsor: Bicara Therapeutics

Sex: All·Age: 18+

Code: NCT06788990·Phase 2, Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

for Chronic Lymphocytic Leukaemia

Sites in Providence +11 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06564038·Phase 1, Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

for Breast Cancer

Drug: Durvalumab

Sites in Providence +35 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06103864·Phase 3·Recruiting·Listed Oct 2023

Apply to this trial

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

for Endometrial Cancer

Drug: Rilvegostomig

Sites in Providence +44 more locations

Sponsor: AstraZeneca

Sex: Female·Age: 18+

Code: NCT06989112·Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors

for Advanced Solid Tumors That Are MTAP Deficient

Sites in Providence +6 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06130553·Phase 1, Phase 2·Recruiting·Listed Nov 2023

Apply to this trial

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

for Heart Failure and Impaired Kidney Function

Drug: Dapagliflozin

Sites in Providence +112 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT06307652·Phase 3·Recruiting·Listed Mar 2024

Apply to this trial

A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors

for ER+ HER2- Advanced Breast Cancer

Sites in Providence +3 more locations

Sponsor: AstraZeneca

Sex: Female·Age: 18+

Code: NCT06188520·Phase 1, Phase 2·Recruiting·Listed Jan 2024

Apply to this trial

Study for AZD4360 in Participants With Advanced Solid Tumours

for Gastric Cancer

Sites in Providence +2 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT06921928·Phase 1, Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for Acute Coronary Syndrome

Sites in Providence +147 more locations

Sponsor: DalCor Pharmaceuticals

Sex: All·Age: 45+

Code: NCT05918861·Phase 3·Recruiting·Listed Jun 2023

Apply to this trial

Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment

for Eosinophilic Asthma

Sites in Warwick +30 more locations

Sponsor: AstraZeneca

Sex: All·Age: 12 - 75

Code: NCT06750289·Phase 3·Recruiting·Listed Dec 2024

Apply to this trial

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

for Multiple Myeloma

Drug: Belantamab mafodotin

Sites in Providence +29 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT06679101·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

for Solid Tumor

Sites in Providence +6 more locations

Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Sex: Female·Age: 18+

Code: NCT04516447·Phase 1·Recruiting·Listed Aug 2020

Apply to this trial

Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis

for Carpometacarpal Sprain

1 location in Providence

Sponsor: Rhode Island Hospital

Sex: All·Age: 18+

Code: NCT05990881·Phase 3·Recruiting·Listed Aug 2023

Apply to this trial